Juan Boriosi, MD, is participating in a clinical trial with Hospira, Inc., entitled, “A Phase III, Randomized, Double-Blind, Dose-Controlled, Multicenter, Study Evaluating the Safety and Efficacy of Dexmedetomidine in Intubated and Mechanically Ventilated Pediatric Intensive …